Los Alamos, NM, United States of America

Bette T Korber

USPTO Granted Patents = 31 (Patent Applications = 13)

CIPO Patents = 5 (Patent Applications = 11)

EPO Patents = 4 (Patent Applications = 21)

Average Co-Inventor Count = 4.7

ph-index = 7

Forward Citations = 206(Granted Patents)

Company Filing History:

Los Alamos National Security, LLC

patents

14 out of 516

Beth Israel Deaconess Medical Center, Inc.

patents

4. 10 out of 287

Triad National Security, LLC

patents

5. 6 out of 516

University of Alabama

patents

6. 4 out of 15,458

University of California

patents

7. 3 out of 580

The Uab Research Foundation

patents

8. 3 out of 2,595

University of Pennsylvania

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

11. 2 out of 5,303

Leland Stanford Junior University

patents

12. 1 out of 1

The University of Albama at Birmingham Research Foundation

patent

13. 1 out of 2

Los Alamos Security, LLC

patents

14. 1 out of 1

U. of Alabama at Birmingham Research Foundation

patent

15. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2006-2024

Loading Chart...

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11884704 - Compositions comprising HIV envelopes to induce CH235 lineage antibodies (2024-01-30),

2. 11773144 - Mosaic HIV-1 envelopes to induce ADCC responses (2023-10-03),

3. 11331386 - Antiviral vaccines with improved cellular immunogenicity (2022-05-17),

4. 11246920 - Compositions and methods for inducing HIV-1 antibodies (2022-02-15),

5. 11230572 - Signature-based human immunodeficiency virus (HIV) envelope (Env) trimer vaccines and methods of using the same (2022-01-25),

6. 10968255 - Compositions comprising HIV envelopes to induce CH235 lineage antibodies (2021-04-06),

7. 10946090 - Consensus/ancestral immunogens (2021-03-16),

8. 10906941 - Methods of inducing an immune response against HIV-1 using recombinant envelopes with improved coverage (2021-02-02),

9. 10849970 - Antibody evolution immunogens (2020-12-01),

10. 10772952 - Antiviral vaccines with improved cellular immunogenicity (2020-09-15),

11. 10426831 - Antiviral vaccines with improved cellular immunogenicity (2019-10-01),

12. 10322141 - Compositions comprising CH848 envelopes and uses thereof (2019-06-18),

13. 10232034 - Compositions comprising CH505 envelopes, and trimers (2019-03-19),

14. 10149902 - Swarm immunization with envelopes from CH505 (2018-12-11),

15. 10076567 - MPER-liposome conjugates and uses thereof (2018-09-18),

Title: The Innovative Journey of Bette T Korber

Introduction: Bette T Korber, a pioneering inventor based in Los Alamos, NM (US), has made significant contributions to the field of science and technology.

Latest Patents: Bette T Korber holds several patents in the areas of biotechnology and bioinformatics, showcasing her dedication to innovation and research.

Career Highlights: With a distinguished career spanning decades, Bette T Korber has been at the forefront of groundbreaking discoveries in the fields of genetics and computational biology. Her work has not only advanced scientific knowledge but has also paved the way for new developments in the industry.

Collaborations: Throughout her career, Bette T Korber has collaborated with leading researchers, scientists, and institutions worldwide, fostering a culture of innovation and knowledge-sharing in the scientific community.

Conclusion: Bette T Korber's relentless pursuit of innovation and her commitment to pushing the boundaries of scientific discovery make her a true trailblazer in the world of inventions and patents. Her work continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.